DYRK1A reinforces epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma via cooperatively activating STAT3 and SMAD
Hepatocellular carcinoma (HCC) accounts for the majority of liver cancer cases, while metastasis is considered the leading cause of HCC-related death. However, the currently available treatment strategies for ...
Source: Journal of Biomedical Science - Category: Biomedical Science Authors: Yang-ling Li, Man-man Zhang, Lin-wen Wu, Ye-han Liu, Zuo-yan Zhang, Ling-hui Zeng, Neng-ming Lin and Chong Zhang Tags: Research Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Carcinoma | Epithelial Cancer | Hepatocellular Carcinoma | Liver | Liver Cancer | Science | Urology & Nephrology